OLANZAPIN APOTEX

5MG POR TBL DIS 28

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Cessation of marketing 06.12.2019 0124009, 0167038, 0184714, 0234620, 0025918, 0029607, 0029609
Commercial/marketing reasons
Resumption of marketing 01.09.2018
Interruption of marketing 31.07.2018 0124009, 0167038, 0184714, 0201204, 0025918, 0029607, 0029609
Resumption of marketing 02.05.2018
Interruption of marketing 31.05.2018 0124009, 0184714, 0201204, 0207694, 0025918, 0029607, 0029609
Resumption of marketing 23.10.2017
Interruption of marketing 30.06.2017 0124009, 0160198, 0184714, 0201204, 0025918, 0029607, 0029609
Resumption of marketing 09.01.2017
Interruption of marketing 29.02.2016 0124009, 0159080, 0160198, 0161296, 0167038, 0184712, 0025918, 0029607, 0029609
Resumption of marketing 27.01.2014
Interruption of marketing 15.11.2013 0124003, 0141770, 0159080, 0160198, 0161296, 0167038, 0176657, 0184002, 0184009, 0184712, 0025918, 0029295, 0029607
Placing on the market 05.01.2010

All reports are available in the Overview.

Back to list